N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors
N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors
Recruiting · NCT07639450 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors | Advanced Malignant Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-09-17 | NCT07639450 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hefei Xinzhu Biological Technology Co., Ltd. | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Corner Edith & Platt Streets, , NSW 2298 Australia | Waratah | Australia | 1 |
| GenesisCare Research | Saint Leonards | Australia | 1 |
| Henan Cancer Hospital | Zhengzhou | China | 2 |
| Hunan Cancer Hospital | Changsha | China | 123 |
| San Clinical Trials Unit | Wahroonga | Australia | 2 |
| Shanghai East Hospital | Shanghai | China | 11 |